Navigation Links
Hudson Valley Fertility Opens First Advanced Fertility Practice in the Hudson Valley
Date:5/12/2008

FISHKILL, N.Y., May 12 /PRNewswire/ -- Hudson Valley Fertility has opened a state-of-the-art center for advanced fertility treatment and In Vitro Fertilization (IVF), making this the only medical practice in the area offering infertility treatment and reproductive health services. Under the direction of Daniel Levine, MD, Hudson Valley Fertility specializes in the diagnosis of reproductive disorders and offers a full range of treatment options, from simple drug therapies to the Assisted Reproductive Technologies.

"Thousands of women and men in upstate New York are affected by infertility and require medical care to help them have a baby. Our new offices in Fishkill were designed specifically with the needs of our patients in mind, ensuring a convenient, comfortable, and private environment, to deliver the most effective infertility treatments available," said Dr. Levine. "We work closely with our patients, providing compassionate, personalized care and support, every step of the way."

Hudson Valley Fertility combines advanced technology with compassion and sensitivity and treatment is personalized, to the needs of individuals and couples. In addition to offering a full range of treatment options, including Preimplantation Genetic Diagnosis (PGD), egg and embryo freezing, gender selection and treatment of recurrent pregnancy loss, Hudson Valley Fertility also offers patients complimentary therapies including acupuncture, herbal treatments, yoga, massage therapy and nutritional awareness. These treatment options are designed to deliver a complete wellness approach to augment and maximize success rates in infertility treatment.

Hudson Valley Fertility was founded by Dr. Daniel Levine. Dr Levine was previously Medical Director of the Sher Institute for Reproductive Medicine (SIRM) in Westchester County, NY, and Attending Physician at SIRM New York City in Manhattan. Dr. Levine also previously founded and was Medical Director of University IVF in Syracuse. He is Board Certified in Obstetrics and Gynecology as well as Reproductive Endocrinology and Infertility. Dr. Levine has lectured extensively and is the author of numerous scientific publications. He is also an expert in advanced endoscopic and laser surgery. As the father of two daughters conceived through IVF, Dr. Levine brings a personal understanding of the difficult journey of infertility treatment.

For appointments and additional information please call Hudson Valley Fertility at 845-765-0125 or visit us on the web at http://www.hudsonvalleyfertility.com

Hudson Valley Fertility in Fishkill, NY, serves patients throughout the Hudson Valley area. Dr. Levine offers a full range of male and female infertility treatments, including ovulation induction and the assisted reproductive technologies (In Vitro Fertilization), and recurrent pregnancy loss. Visit http://www.hudsonvalleyfertility.com.


'/>"/>
SOURCE Hudson Valley Fertility
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hooper Holmes Appoints Leslie Hudson, PhD, to Board of Directors
2. ULLICO Casualty Group Aligns with Hudson Insurance Company to Offer Fiduciary and Union Liability Insurance
3. Grey House Publishing Acquires Hudsons Washington News Media Contacts Directory
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. Shopko Express Coming to the Fox Valley
6. NNN Healthcare/Office REIT Acquires 2750 Monroe Boulevard in Valley Forge, Pennsylvania
7. IMA South American Extravaganza Dinner to Honor Coachella Valley Doctor
8. Aegis Selected by Community Medical Centers to Bring New Employer-Focused Wellness Program to Californias Central Valley
9. Valley Health System Caregivers, Members of SEIU UHW, to Announce Endorsement of Measure G
10. Pacific Valley Bank Approves $16.7 Million Loan to Mee Memorial Hospital for Healthcare Services in South Monterey County
11. Halloween Events in Central Valley, Calif. Bring Young and Old Together for a Ghoulish Good Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental ... Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues related ... and prosthetic market in the U.S. is projected to reach $6.4 billion in 2018 ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... was set up in 2006 as a non-profit organization to unite pharmaceutical and ...
(Date:12/8/2016)... ... 08, 2016 , ... Healthcare is in flux. The GOP ... the mass media launching of story movements to highlight what's most unfair about ... experiences; such a movement can generate the network power to improve healthcare policies ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, an ... around the greater Phoenix metropolitan region, is announcing a charity event to provide ... the Homeless Youth Connection is to promote community awareness of the ongoing needs ...
(Date:12/7/2016)... ... 07, 2016 , ... DrugDev again demonstrated its dedication to reducing ... the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of Commerce. ... sides of the Atlantic with a mechanism to comply with EU data protection requirements ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016   TriNetX , the health research ... signed a membership agreement to join the ... new cures. The TriNetX network is ... patients globally, biopharmaceutical companies and contract research organizations ... design, site selection, patient recruitment, and collaborative research ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals International, ... VRX) ("Valeant") today announced positive results from a ... to assess the safety and efficacy of IDP-118 ... of plaque psoriasis. Within the ... moderate to severe psoriasis, IDP-118 showed statistical significance ...
(Date:12/8/2016)... 8, 2016  EIP Pharma, LLC ( www.eippharma.com ... for neflamapimod (previously code named VX-745), with the ... trials that demonstrated significant Alzheimer,s disease relevant pharmacological ... and Study 303 (6-week treatment) are the subject ... Disease (CTAD) scientific conference in San ...
Breaking Medicine Technology: